Individual dosimetry and monitoring response to treatment in tandem PRRT with [177Lu/90Y]-DOTA-TATE
By:
Krzysztof Kacperski
, Anna Budzyńska, Agata Kubik, Patrycja Pastusiak, Wioletta Chalewska, Wioletta Lenda-Tracz, Anna Borkowska, Agata Walecka-Mazur, Artur Szczodry, Janusz Braziewicz, Maciej Kołodziej, Grzegorz Kamiński, Marek Dedecjus, Joanna Długosińska, Joanna Januszkiewicz-Caulier, Alicja Hubalewska-Dydejczyk, Marta Opalińska, Aldona Kowalska and Renata Mikołajczak
, Anna Budzyńska, Agata Kubik, Patrycja Pastusiak, Wioletta Chalewska, Wioletta Lenda-Tracz, Anna Borkowska, Agata Walecka-Mazur, Artur Szczodry, Janusz Braziewicz, Maciej Kołodziej, Grzegorz Kamiński, Marek Dedecjus, Joanna Długosińska, Joanna Januszkiewicz-Caulier, Alicja Hubalewska-Dydejczyk, Marta Opalińska, Aldona Kowalska and Renata Mikołajczak References
- Fani M, Maecke HR, Okarvi SM. Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer. Theranostics. 2012;2(5):481-501. https://doi.org/10.7150/thno.4024
- Loharkar S, Basu S. Peptide receptor radionuclide therapy in neuroendocrine neoplasms and related tumors: from fundamentals to personalization and the newer experimental approaches. Expert Review of Precision Medicine and Drug Development. 2023;8(1):1-32. https://doi.org/10.1080/23808993.2023.2211090
- Gabriel M, Nilica B, Kaiser B, Virgolini IJ. Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy. J Nucl Med. 2018;60(4):524-529. https://doi.org/10.2967/jnumed.118.215376
- Sandström M, Garske-Román U, Johansson S, Granberg D, Sundin A, Freedman N. Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance. Acta Oncologica. 2017;57(4):516-521. https://doi.org/10.1080/0284186X.2017.1378431
- Marin G, Vanderlinden B, Karfis I, et al. A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours. Physica Medica. 2018;56:41-49. https://doi.org/10.1016/j.ejmp.2018.11.001
- Santoro L, Mora-Ramirez E, Trauchessec D, et al. Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate. EJNMMI Res. 2018;8(1). https://doi.org/10.1186/s13550-018-0459-4
- Zaknun JJ, Bodei L, Mueller-Brand J, et al. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2013;40(5):800-816. https://doi.org/10.1007/s00259-012-2330-6
- Haug AR. PRRT of neuroendocrine tumors: individualized dosimetry or fixed dose scheme? EJNMMI Res. 2020;10(1). https://doi.org/10.1186/s13550-020-00623-3
- Opalińska M, Kamiński G, Dedecjus M, et al. DUONEN multicenter study - personalized PRRT treatment with 177Lu- or 177Lu/90YDOTA-TATE in patients with neuroendocrine tumors based on individual dosimetry. Endocrine Abstracts. 2023;90:P440. https://doi.org/10.1530/endoabs.90.P440
- Siegel JA, Thomas SR, Stubbs JB, et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. Journal of Nuclear Medicine. 1999;40(2):37S-61S.
- Hindorf C, Glatting G, Chiesa C, Lindén O, Flux G. EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging. 2010;37(6):1238-1250. https://doi.org/10.1007/s00259-010-1422-4
- Hwang SH, Jung M, Jeong YH, et al. Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18FFDG PET/CT in patients with localized primary gastrointestinal stromal tumors. Cancer Metab. 2021;9(1). https://doi.org/10.1186/s40170-021-00244-x
- Chicheportiche A, Ben-Haim S, Grozinsky-Glasberg S, et al. Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management. EJNMMI Phys. 2020;7(1). https://doi.org/10.1186/s40658-020-0273-8
Language: English
Submitted on: Nov 6, 2024
Accepted on: Dec 3, 2024
Published on: Dec 31, 2024
Published by: Polish Society of Medical Physics
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2024 Krzysztof Kacperski, Anna Budzyńska, Agata Kubik, Patrycja Pastusiak, Wioletta Chalewska, Wioletta Lenda-Tracz, Anna Borkowska, Agata Walecka-Mazur, Artur Szczodry, Janusz Braziewicz, Maciej Kołodziej, Grzegorz Kamiński, Marek Dedecjus, Joanna Długosińska, Joanna Januszkiewicz-Caulier, Alicja Hubalewska-Dydejczyk, Marta Opalińska, Aldona Kowalska, Renata Mikołajczak, published by Polish Society of Medical Physics
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.